InvestorsHub Logo

DaubersUP

07/16/19 11:28 AM

#267548 RE: zandant #267546

10-k due in Sept. if we dont hear by then, you’ll see it posted.

Leo and Dr B are very quiet. Very

I say we see a deal soon.

My company just did another acquisition and it took 7 months and we still are waiting on a few foreign agencies to approve.

Stuff takes time. That was only a 100 million acquisition. I think IPIX sees multiples of that in a first license deal

kfcyahoo

07/16/19 11:43 AM

#267552 RE: zandant #267546

I called this morning, got an answering machine which said, among other things, " if you know the persons extension please dial it" now" (something like that). Started with ext 101 and went to 109(had to call back a few times as it allow 3 attempts before tossing you back to secretary's voice mail. 101,103, 104, 106, 107, 108, 109 all were described as invalid extensions. 102 is Anita Menon Beechan's ext(got voicemail, no live voice), and ext 105 is Nancy C (almost sounded like Chandelier) which went straight to voicemail as well.
Lost patience and hung up.

loanranger

07/16/19 2:03 PM

#267568 RE: zandant #267546

XIII.COMMUNICATIONS BY STOCKHOLDERS WITH DIRECTORS
Stockholders may communicate with any and all directors of the Company by mail to the following address:
Corporate Secretary Innovation Pharmaceuticals Inc.100 Cummings Center, Suite 151-BBeverly, Massachusetts01915

Each communication should specify the applicable addressee or addressees to be contacted as well as the general topic of the communication. The Corporate Secretary will maintain a log of such communications and will initially receive and process communications before forwarding them to the addressee. The Corporate Secretary generally will not forward to the directors a communication that he or she determines to be primarily commercial in nature or related to an improper or irrelevant topic, or that requests general information about the Company.

https://static1.squarespace.com/static/5715352e20c647639137f992/t/59885f8137c5815a822a2313/1502109570080/IPIX+-+Corporate+Governance+Guidelines.pdf